Evidence map

ReviewPharmaceutics2022

Nanotechnology in Immunotherapy for Type 1 Diabetes: Promising Innovations and Future Advances.

Saumya Nigam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

4 papers cite it

2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 35336018